• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬腹水中的谷氨酰胺和谷氨酸

Glutamine and glutamate in ascitic fluid of dogs.

作者信息

Hirschberger J, Goldberg M, Sauer U G

机构信息

I. Medizinische Tierklinik, University of Munich, Federal Republic of Germany.

出版信息

Eur J Clin Chem Clin Biochem. 1993 Feb;31(2):103-6. doi: 10.1515/cclm.1993.31.2.103.

DOI:10.1515/cclm.1993.31.2.103
PMID:8096769
Abstract

The amino acid pattern in the ascites of 79 dogs was examined. The concentration of glutamine in neoplastic ascites is significantly lower than in cardial effusions. In contrast, glutamate is significantly higher in neoplastic ascites than in cardial ascites. Using an arbitrary discrimination value of 0.28 for the glutamate/glutamine ratio, purulent or cardial ascites are easily differentiated, with a sensitivity of 100% and a specificity of 94%. The differentiation is very distinct, with no overlap between the group of patients with liver cirrhosis on the one hand and the groups of patients with purulent peritonitis, heart failure, or malignant ascites on the other hand. There was no diagnostically unsable correlation between the concentrations of the other 20 amino acids and the underlying causes of ascites formation.

摘要

对79只犬的腹水氨基酸模式进行了检测。肿瘤性腹水中谷氨酰胺的浓度显著低于心性积液中的浓度。相反,肿瘤性腹水中谷氨酸盐的含量显著高于心性腹水中的含量。以谷氨酸盐/谷氨酰胺比值0.28作为任意判别值,可轻松区分脓性或心性腹水,敏感性为100%,特异性为94%。这种区分非常明显,一方面肝硬化患者组与另一方面脓性腹膜炎、心力衰竭或恶性腹水患者组之间没有重叠。其他20种氨基酸的浓度与腹水形成的潜在原因之间不存在诊断上无用的相关性。

相似文献

1
Glutamine and glutamate in ascitic fluid of dogs.犬腹水中的谷氨酰胺和谷氨酸
Eur J Clin Chem Clin Biochem. 1993 Feb;31(2):103-6. doi: 10.1515/cclm.1993.31.2.103.
2
Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.腹水的止血研究结果:70只犬的横断面研究
J Vet Intern Med. 2017 Jan;31(1):43-50. doi: 10.1111/jvim.14610. Epub 2016 Nov 16.
3
[Effusions in the dog. 1. Clinico-diagnostic study with special reference to the cytology of the fluid].[犬的积液。1. 临床诊断研究,特别参考液体的细胞学]
Tierarztl Prax. 1975;3(4):477-88.
4
[Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].[肝硬化合并自发性细菌性腹膜炎患者腹水中白细胞介素-7表达水平的临床意义]
Zhonghua Gan Zang Bing Za Zhi. 2019 Apr 20;27(4):274-280. doi: 10.3760/cma.j.issn.1007-3418.2019.04.007.
5
High protein ascites in patients with uncomplicated hepatic cirrhosis.单纯性肝硬化患者的高蛋白腹水
Am J Med Sci. 1974 May;267(5):275-9. doi: 10.1097/00000441-197405000-00003.
6
Antibiotic concentrations in ascitic fluid of patients with ascites and bacterial peritonitis.腹水合并细菌性腹膜炎患者腹水中的抗生素浓度。
Ann Intern Med. 1977 Jun;86(6):708-13. doi: 10.7326/0003-4819-86-6-708.
7
[Clinico-chemical study of body cavity effusions].[体腔积液的临床化学研究]
Tierarztl Prax. 1991 Aug;19(4):431-4.
8
Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.患有自发性细菌性腹膜炎、恶性腹水和肝硬化腹水的患者。
J Natl Med Assoc. 2005 Feb;97(2):276-80.
9
Lactate as a diagnostic test for septic peritoneal effusions in dogs and cats.乳酸作为犬猫感染性腹腔积液的诊断试验。
J Am Anim Hosp Assoc. 2004 Sep-Oct;40(5):364-71. doi: 10.5326/0400364.
10
Analysis of ascitic fluid in cirrhosis.肝硬化腹水分析
Dig Dis Sci. 1979 Feb;24(2):136-44. doi: 10.1007/BF01324741.

引用本文的文献

1
N-terminal brain natriuretic peptide, cardiac troponin-I, and point-of-care ultrasound in dogs with cardiac and noncardiac causes of nonhemorrhagic ascites.N 端脑利钠肽、心肌肌钙蛋白 I 和即时超声在伴有非出血性腹水的心脏和非心脏原因犬中的应用。
J Vet Intern Med. 2023 May-Jun;37(3):900-909. doi: 10.1111/jvim.16702. Epub 2023 Apr 15.
2
A Metabolomic Analysis of Cirrhotic Ascites.肝硬化性腹水的代谢组学分析。
Molecules. 2022 Jun 20;27(12):3935. doi: 10.3390/molecules27123935.
3
Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion.
卵巢癌球体在黏附过程中的代谢重编程
Cancers (Basel). 2022 Mar 9;14(6):1399. doi: 10.3390/cancers14061399.